Literature DB >> 16897605

Prion protein gene M129 allele is a risk factor for Alzheimer's disease.

M Gacia1, K Safranow, M Styczyńska, K Jakubowska, B Pepłońska, M Chodakowska-Zebrowska, I Przekop, A Słowik, E Golańska, K Hułas-Bigoszewska, D Chlubek, D Religa, C Zekanowski, M Barcikowska.   

Abstract

Prion protein gene polymorphism M129V represents a known risk factor for Creutzfeldt-Jakob disease. Recently, the meta-analysis revealed that homozygosity at codon 129 is connected with increased risk of Alzheimer's disease (AD). To determine whether M129V polymorphism is a risk factor for AD we analyzed a group of early-onset, and late-onset Polish AD patients. We observed that in LOAD patients there is a statistically significant increase of MM (p=0.0028) and decrease of MV (p=0.0006) genotype frequency, as compared to controls. When both groups were stratified according to APOE4 status, increase of MM and decrease of MV genotype frequency were significant in the LOAD subgroup with no APOE4 (p=0.017, and p=0.018, respectively). In the subgroup with APOE4 allele, only MV genotype frequency was significantly lower, as compared to controls (p=0.035). However, no interaction was found between APOE4 status and M129V polymorphism. We conclude that MM genotype increases LOAD risk in Polish population independently from the APOE4 status.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16897605     DOI: 10.1007/s00702-006-0540-4

Source DB:  PubMed          Journal:  J Neural Transm (Vienna)        ISSN: 0300-9564            Impact factor:   3.575


  29 in total

1.  Prion protein expression in senile plaques in Alzheimer's disease.

Authors:  I Ferrer; R Blanco; M Carmona; B Puig; R Ribera; M J Rey; T Ribalta
Journal:  Acta Neuropathol       Date:  2001-01       Impact factor: 17.088

2.  Mutation analysis of MLH1 and MSH2 genes performed by denaturing high-performance liquid chromatography.

Authors:  Grzegorz Kurzawski; Krzysztof Safranow; Janina Suchy; Dariusz Chlubek; Rodney J Scott; Jan Lubiński
Journal:  J Biochem Biophys Methods       Date:  2002-03-04

3.  PRNP Val129 homozygosity increases risk for early-onset Alzheimer's disease.

Authors:  Bart Dermaut; Esther A Croes; Rosa Rademakers; Marleen Van den Broeck; Marc Cruts; Albert Hofman; Cornelia M van Duijn; Christine Van Broeckhoven
Journal:  Ann Neurol       Date:  2003-03       Impact factor: 10.422

4.  A rapid and efficient method for the detection of point mutations of the human prion protein gene (PRNP) by direct sequencing.

Authors:  R Petraroli; G Vaccari; M Pocchiari
Journal:  J Neurosci Methods       Date:  2000-06-30       Impact factor: 2.390

5.  Biochemical and structural studies of the prion protein polymorphism.

Authors:  C Petchanikow; G P Saborio; L Anderes; M J Frossard; M I Olmedo; C Soto
Journal:  FEBS Lett       Date:  2001-12-14       Impact factor: 4.124

6.  Homozygous prion protein genotype predisposes to sporadic Creutzfeldt-Jakob disease.

Authors:  M S Palmer; A J Dryden; J T Hughes; J Collinge
Journal:  Nature       Date:  1991-07-25       Impact factor: 49.962

7.  The -22c/t polymorphism in presenilin 1 gene is not connected with late-onset and early-onset familial Alzheimer's disease in Poland.

Authors:  C Zekanowski; D Religa; K Safranow; A Maruszak; V Dziedziejko; M Styczyńska; M Gacia; M Golan; B Pepłońska; D Chlubek; J Kuźnicki; M Barcikowska
Journal:  J Neural Transm (Vienna)       Date:  2004-10-12       Impact factor: 3.575

8.  Polymorphism of the prion protein is associated with cognitive impairment in the elderly: the EVA study.

Authors:  C Berr; F Richard; C Dufouil; C Amant; A Alperovitch; P Amouyel
Journal:  Neurology       Date:  1998-09       Impact factor: 9.910

9.  Polymorphisms within the prion (PrP) and prion-like protein (Doppel) genes in AD.

Authors:  E Golanska; K Hulas-Bigoszewska; E Rutkiewicz; M Styczynska; B Peplonska; M Barcikowska; J Bratosiewicz-Wasik; P P Liberski
Journal:  Neurology       Date:  2004-01-27       Impact factor: 9.910

10.  Prion protein gene polymorphism and Alzheimer's disease: one modulatory trait of cognitive decline?

Authors:  V M Casadei; C Ferri; E Calabrese; L M Grimaldi; M Franceschi; F Veglia; F Licastro; C Mariani
Journal:  J Neurol Neurosurg Psychiatry       Date:  2001-08       Impact factor: 10.154

View more
  12 in total

1.  The prion protein M129V polymorphism: longevity and cognitive impairment among Polish centenarians.

Authors:  Ewa Golanska; Monika Sieruta; Elizabeth Corder; Sylwia M Gresner; Anna Pfeffer; Malgorzata Chodakowska-Zebrowska; Tomasz M Sobow; Izabela Klich; Malgorzata Mossakowska; Aleksandra Szybinska; Maria Barcikowska; Pawel P Liberski
Journal:  Prion       Date:  2013-02-13       Impact factor: 3.931

Review 2.  Alzheimer's disease and prion protein.

Authors:  Jiayi Zhou; Bingqian Liu
Journal:  Intractable Rare Dis Res       Date:  2013-05

3.  β-amyloid oligomers and prion protein: Fatal attraction?

Authors:  Gianluigi Forloni; Claudia Balducci
Journal:  Prion       Date:  2011-01-01       Impact factor: 3.931

4.  The cellular prion protein traps Alzheimer's Aβ in an oligomeric form and disassembles amyloid fibers.

Authors:  Nadine D Younan; Claire J Sarell; Paul Davies; David R Brown; John H Viles
Journal:  FASEB J       Date:  2013-01-18       Impact factor: 5.191

Review 5.  Can infections cause Alzheimer's disease?

Authors:  Francis Mawanda; Robert Wallace
Journal:  Epidemiol Rev       Date:  2013-01-24       Impact factor: 6.222

Review 6.  Inclusion body myositis: a view from the Caenorhabditis elegans muscle.

Authors:  Daniela L Rebolledo; Alicia N Minniti; Paula M Grez; Ricardo Fadic; Rebecca Kohn; Nibaldo C Inestrosa
Journal:  Mol Neurobiol       Date:  2008-09-05       Impact factor: 5.590

7.  The methionine-aromatic motif plays a unique role in stabilizing protein structure.

Authors:  Christopher C Valley; Alessandro Cembran; Jason D Perlmutter; Andrew K Lewis; Nicholas P Labello; Jiali Gao; Jonathan N Sachs
Journal:  J Biol Chem       Date:  2012-08-01       Impact factor: 5.157

8.  Genetic cross-interaction between APOE and PRNP in sporadic Alzheimer's and Creutzfeldt-Jakob diseases.

Authors:  Olga Calero; María J Bullido; Jordi Clarimón; Ana Frank-García; Pablo Martínez-Martín; Alberto Lleó; María Jesús Rey; Alberto Rábano; Rafael Blesa; Teresa Gómez-Isla; Fernando Valdivieso; Jesús de Pedro-Cuesta; Isidro Ferrer; Miguel Calero
Journal:  PLoS One       Date:  2011-07-20       Impact factor: 3.240

9.  Cellular prion protein expression is not regulated by the Alzheimer's amyloid precursor protein intracellular domain.

Authors:  Victoria Lewis; Isobel J Whitehouse; Herbert Baybutt; Jean C Manson; Steven J Collins; Nigel M Hooper
Journal:  PLoS One       Date:  2012-02-21       Impact factor: 3.240

10.  A patient with posterior cortical atrophy possesses a novel mutation in the presenilin 1 gene.

Authors:  Emilia J Sitek; Ewa Narożańska; Beata Pepłońska; Sławomir Filipek; Anna Barczak; Maria Styczyńska; Krzysztof Mlynarczyk; Bogna Brockhuis; Erik Portelius; Dorota Religa; Maria Barcikowska; Jarosław Sławek; Cezary Żekanowski
Journal:  PLoS One       Date:  2013-04-12       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.